Latest news with #PNN
Business Standard
a day ago
- Health
- Business Standard
World No Tobacco Day 2025: Experts Unite Against Tobacco as a Leading Cause of Cancer and Chronic Diseases
PNN New Delhi [India], May 31: On the occasion of World No Tobacco Day, observed every year on May 31, leading healthcare experts across the country are sounding a clarion call against one of the biggest threats to global health: tobacco. Beyond awareness, experts are demanding urgent action, highlighting tobacco's devastating and far-reaching effects -- from cancer, respiratory, and cardiovascular disease to infertility and second-hand smoke exposure. India currently faces over 37.5 lakh active cancer cases, and tobacco remains the single largest preventable cause. According to a global study published in The Lancet's eClinical Medicine, tobacco-related illnesses cause over 1.3 million cancer-related deaths annually across seven countries, including India. "Smoking is one of the worst carcinogens in the world. Tobacco exposes the entire body, not just the lungs, to cancer-causing agents. It's linked to multiple cancers, including those of the lung, mouth, throat, esophagus, larynx, pancreas, bladder, kidney, stomach, cervix, colon, and even blood cancers like acute myeloid leukemia (AML)," said Dr. Dinesh Singh, Director and Head, Radiation Oncology, Action Cancer Hospital, Delhi. Dr. Singh further warns about second-hand smoke, stating that even non-smokers exposed to it absorb carcinogens and face a significantly elevated cancer risk, especially for lung cancer. "Tobacco smoke promotes chronic inflammation, triggering genetic instability and abnormal cell growth -- a key environment for cancer to develop. Nearly every organ in the body is affected," he explained. Dr. Pritpal Kaur, Pulmonologist, Apollo Spectra Hospital, Karol Bagh, Delhi said, "Tobacco is a toxic cocktail that attacks the respiratory system at every level--from inflaming the airways to permanently damaging lung tissues. COPD, asthma, lung cancer, and bronchitis are just the tip of the iceberg. Tobacco doesn't just suffocate the lungs--it wreaks havoc across the entire body. Every puff poisons not just the smoker, but everyone around them." As India continues to battle its cancer burden, Bengaluru-based SPARSH Group of Hospitals has taken a bold step forward. On May 18, 2025, SPARSH launched its flagship 300-bed multi-speciality hospital on Hennur Road, Bengaluru, introducing its first comprehensive cancer care facility. Backed by world-class infrastructure and an expert team across 50 specialities, the hospital features 75 ICU beds and an integrated oncology program. Dr. Vivek Shetty, Senior Consultant- Head & Neck Oncology, SPARSH Hospital, Hennur Road, Bengaluru said, "Along with lung cancer, oral cancer is also alarmingly common among people who smoke or use tobacco in other forms. There is an urgent need to increase awareness about early detection through proper screening and to encourage timely treatment." "With our new facility at Hennur Road, we now offer best-in-class comprehensive cancer care to combat these life-threatening diseases. Our mission is to bring comprehensive cancer treatment to the doorsteps of people in Karnataka, especially Bengaluru and its neighbouring regions," added Dr. Shetty. The hospital's approach marries precision medicine, compassion, and accessibility, making it a timely answer to Karnataka's growing cancer crisis, where 86,563 new cases are projected annually, with lung and mouth cancers comprising nearly 16% of male cancers. Whether smoked or chewed, tobacco remains the most potent and preventable health hazard. And the consequences go beyond cancer, heart disease, stroke, reproductive disorders, and chronic lung diseases, all bear its imprint. "Tobacco addiction is difficult but not impossible to beat. With modern therapies, counselling, and the right intent, recovery is possible. Every cigarette not smoked is a step toward healing -- not just for the smoker, but for their entire family, said Dr. Arun Kumar Verma, Senior Consultant- Oncology, Chhatrapati Shivaji Subharti Hospital, Meerut. "From lung, oral, and throat cancers to bladder and oesophageal malignancies, tobacco is a common denominator. What's worrying is that even people exposed to secondhand smoke--like family members or co-workers-are--are at risk," warned Dr. Verma, adding, "We must dispel the myth of 'safe usage'. There is no safe level of tobacco exposure." Experts concluded that with early detection, structured cessation programs, and accessible treatment, outcomes can dramatically improve. But quitting tobacco should also be a top priority.
&w=3840&q=100)
Business Standard
a day ago
- Business
- Business Standard
Aristo Bio-Tech FY25 PAT Rises to Rs 4.06 Cr, Revenue Jumps 30 Percent to Rs 318.09 Cr
PNN New Delhi [India], May 31: Gujarat-based Aristo Bio-Tech and Lifescience Ltd, a fast-growing company in the agrochemical and biotechnology space, has reported a stellar financial performance for the fourth quarter and full financial year ended March 31, 2025 (FY25). The company posted a strong turnaround in profitability, with significant growth in revenue. Due to expansion and increased capital expenditure, depreciation has risen by Rs. 1 crore compared to last year, resulting in a lower visible profit. For the financial year that ended on March 31, 2025, the company recorded revenue of Rs. 318.09 crore, marking a 30% increase from Rs. 245.15 crore in FY24. Net profit rose to Rs. 4.06 crore, slightly higher than Rs. 3.89 crore in FY24, despite a significant increase in operating scale and investment in expansion. Earnings per share for FY25 stands at Rs. 5.97, a Y-o-Y increase of 4.3% compared to earnings per share of Rs. 5.72 in FY24. The company operates in a promising industry focused on producing and distributing pesticides and fertilizers, helping improve crop yield and quality, offering strong opportunities for the company's sustained growth. Narendra Singh Barhat, Chairman & Managing Director, Aristo Bio-tech and Lifescience said, "FY25 has been a significant year for Aristo. Despite a challenging macroeconomic environment, we delivered strong growth, driven by our operational excellence and strategic investments. Due to expansion and increased capital expenditure, depreciation has risen by Rs. 1 crore compared to last year, resulting in a lower visible profit. We remain committed to delivering value to our shareholders while continuing to expand our market reach and innovation in agri-biotech solutions." Highlights: * Vadodara-based agrochemical company has reported Net Profit of Rs 4.06 crores for FY25 * For FY25, revenue from operations was reported at Rs 318.09 crore, a 30% Y-o-Y growth * Company's distribution network extends over 20 states in India while export network spans over 15 countries * Engaged in the field of producing and distributing pesticides and fertilizers, company has strong growth prospects During the first half of FY25 (April-September 2024), the company recorded a net profit of Rs. 4.55 crore and revenue from operations of Rs. 214.15 crore, reflecting strong growth momentum. However, the second half (October 2024- March 2025) saw a marginal loss of Rs. 49 lakh on revenue of Rs. 104.17 crore, impacted by seasonality and increased input costs. Aristo Bio-Tech and Lifescience product distribution network extendes over 20 states of India. The company also exports to over 15 countries, including Armenia, Australia, Bangladesh, Belgium, Cambodia, Germany, Italy, Kenya, Moldova, New Zealand, Poland, South Africa, UAE, Ukraine, and Vietnam. Company's products include herbicides/weedicides, fungicides, plant growth regulator and insecticides About Aristo Bio-Tech and Lifescience Limited: Incorporated in 2005, Aristo Bio-Tech and Lifescience Limited is an agrochemical company, mainly engaged in the manufacturing, formulation, supplying, packaging, and job work services of various Pesticides. The company delivers products in India as well as engage in exporting products like Insecticides, Herbicides, Fungicides, Plant Growth Regulators, and a wide variety of other Agrochemicals. The company is ISO 9001: 2015 certified for their Quality Management System. Alongside undertaking manufacturing operations, the company also provide Contract manufacturing, Job work and Toll manufacturing services for Crop Protection companies.
Business Standard
a day ago
- Business
- Business Standard
Aayush Wellness's FY25 Revenue Rockets 8,645%, Net Profit Soars 489%
PNN New Delhi [India], May 31: Aayush Wellness Limited (BSE:539528), India's leading preventive healthcare company, has reported excellent results for the financial year 2024-25, reflecting robust growth. The company registered revenue of Rs. 7,338.59 lakh for the financial year 2024-25, a remarkable surge of 8,645% from Rs. 83.92 lakh in the previous financial year. The company's net profit for 2024-25 stood at Rs. 336.58 lakh, reflecting a growth of 489% over the profit of Rs. 57.18 lakh in the previous fiscal year. Aayush Wellness registered a net profit of Rs. 109.3 lakh in the fourth quarter of the financial year 2024-25, an increase of 546.6% from Rs. 16.85 lakh in the corresponding quarter in the previous fiscal year. Revenue for the latest quarter was Rs. 2,236.81 lakh, an increase of 59,000% over the previous year, underscoring strong demand for its health and wellness portfolio. Commenting on the excellent financial performance, Naveena Kumar, Managing Director of Aayush Wellness Limited, said, "We have demonstrated remarkable growth in the last quarter and the whole of the financial year. The revenue, EBITDA and net profit for the financial year were the highest yet in our history. There is strong momentum across all our product verticals, and with several new launches lined up, we are confident of accelerating our growth in the coming quarters." The shares of Aayush Wellness closed at Rs. 134.28 on Friday, 2% higher than the previous close. The shares have been on a roll and are up by more than 10% in the past week, 51% in the last month, 103% in the last three months, and 689% in the last year. The stock has delivered more than 6,500% returns in the last two years and a staggering 9,000% in the last three years. Strengthening its presence in the healthcare market, Aayush Wellness launched its first healthcare centre in Mumbai's Virar. At its core is a smart Health ATM capable of performing a wide range of diagnostic tests in just 2-3 minutes. The innovation not only enables early detection and preventive care but also empowers individuals, especially those in rural and semi-urban areas, to take charge of their health in an accessible, cost-effective manner. Aayush Wellness focuses on critical areas such as tobacco de-addiction, nutrition, and holistic health improvement. Its offerings include Dreamy Sleep Gummies, Beauty Vitamin Gummies, and Aayush Herbal Masala, and it is poised to capture opportunities in the rapidly growing nutritional and fortified food segments.
Business Standard
a day ago
- Business
- Business Standard
IFL Enterprises Ltd reports stellar turnaround in FY25; PAT up 348 Percent Y-o-Y to Rs. 3.04 crore in Q4FY25
PNN Ahmedabad (Gujarat) [India], May 31: Gujarat based IFL Enterprises Ltd (BSE-540377) - engaged in the agri commodity business including import, export and trading of agri commodities has successfully turnaround its business operations in Q4 and FY202425. Company has reported consolidated net profit of Rs. 3.04 crore in Q4 FY25 as compared to loss of Rs 67.87 lakh in corresponding quarter of the previous financial year. Revenue from operations during Q4FY25 reported rise multifold to Rs. 72.13 crore as against revenue of Rs. 1.98 crore in the Q4 FY24. Highlights:- * For FY25, Net Profit rise 254% Y-o-Y to Rs. 2.99 crore; Revenue rise 13 fold to Rs. 120.60 crore * Company successfully raised Rs. 49.53 crore from Rights issue to fund working capital requirements, general corporate purposes * Company expanded domains such as trading of agricultural produce, including fruits, vegetables, seeds, organic products, herbal products, and agri-commodities. The stock price on 30th May was locked in the 20% upper circuit on high volume on BSE. Share price made an intraday high of Rs. 99 paisa per share from Rs. 83 paisa per share from Thursday close. For the financial year that ended March 2025, company achieved revenue from operations of Rs. 120.60 crore, over 13 fold rise as compared to the revenue of Rs. 8.24 crore in the FY 2023-24. Net profit also rose to Rs. 2.99 crores for the FY25, compared to Rs. 84.5 lakh in FY24, a 254% Y-o-Y growth. Company successfully raised Rs. 49.53 crore rights issue in June 2024 to fund its expansion plans including funding the working capital requirements, general corporate purposes etc. The rights issue was subscribed 1.21 times. * Revenue rise multifold to Rs. 72.13 crore in Q4FY25 * Stock price on Friday, 30th May closed with 20% gain In August 2024, company board approved bonus issue in the ratio of 1:150 (1 equity share as bonus for every 150 shares) hed by the equity shareholders. To further expand its business horizons, in 2024, the company approved resolutions to increase its authorized share capital and alter its main objects. This move aims to facilitate the company's entry into new business domains, such as the import, export, or trading of agricultural produce, including fruits, vegetables, seeds, organic products, herbal products, and agri-commodities. Addition to the Agri-comodities business remaining fund will be allocated to stock trading business. This fund will be used to diversify portfolio, implement advanced trading tools and technologies, and capitalize on emerging market opportunities. The focus will be on optimizing trading strategies, enhancing risk management, and achieving superior returns for our investments. Incorporated in the year 2009, IFL Enterprises Ltd currently deals in the agri commodity business including import, export of agriculture produce like fruits, vegetable, seeds, organic and herbal products, trading of agri commodity products including contract farming and warehousing. Company also deals in trading financial instruments like shares, stocks, and bonds. Board of directors on 7th March 2025 has appointed Mr. Sarang Likhitkar as Chief Financial Officer.
Business Standard
2 days ago
- Entertainment
- Business Standard
TCL Redefines Entertainment: Master the Moment with Q6C Premium QD Mini LED Google TV Now in India!
PNN New Delhi [India], May 30: TCL, a global trailblazer in the world of smart entertainment and consistently ranked among the top TV brands worldwide, is electrifying the Indian market with the launch of the revolutionary TCL Q6C! This isn't just an upgrade; it's a complete reimagining of your home entertainment experience, seamlessly fusing the breathtaking brilliance of Premium QD Mini LED Google TV with an intelligent ecosystem designed for modern living. TCL Q6C: Master the Moment. Just as the legendary cricketer Rohit Sharma, exclusively represented by RISE Worldwide, commands attention with his masterful consistency and dazzling performances, TCL has earned its reputation as a trusted innovator, consistently delivering cutting-edge technology that exceeds expectations. The arrival of the Q6C underscores our unwavering commitment to pushing the boundaries of premium innovation, bringing you a viewing experience that is simply unparalleled. "At TCL, we believe that entertainment should transcend mere observation; it should be an immersive, living experience," states Philip Xia, General Manager, TCL India. "With the Q6C, we've meticulously crafted a synergy of revolutionary display technology, intuitive smart features powered by Google TV, and an elegant design that elevates any space. We're not just offering a television; we're offering a gateway to extraordinary moments, accessible to all who seek the best." Unlock a New Dimension of Entertainment: Key Features That Define the Q6C Experience! Prepare to be spellbound by the exceptional features that make the TCL Q6C the ultimate choice: -Witness a Billion Shades Come Alive with QD Mini LED Brilliance & Colourful Quantum Crystals: Prepare your eyes for a visual feast! Our state-of-the-art QD Mini LED Display, enriched with Colourful Quantum Crystals and Wide Colour Gamut (WCG) technology, unleashes a breathtaking spectrum of over one billion vibrant colours. Experience images with profound depth, striking contrast, and an unparalleled level of realism that will make every scene leap off the screen. -Experience Unmatched Picture Precision with All Domain Halo Control Technology & Bionic Colour Optimization Technology: Prepare for visuals that redefine clarity! Our innovative All Domain Halo Control Technology, featuring advanced local dimming zones, works in tandem with the Bionic Colour Optimization Technology to deliver exceptional contrast, minimize blooming, and optimize colour accuracy for a picture that's both natural and breathtaking. -Dive into a Seamless World of Content with Google TV OS: Your entertainment universe, effortlessly organized! The intuitive Google TV OS provides a gateway to a vast library of content, intelligently curating recommendations and delivering a personalized experience tailored just for you. Say goodbye to endless scrolling and hello to seamless discovery. -Experience Visual Perfection with Dolby Vision & HDR10+: Prepare for visuals that pop with breathtaking dynamism! The cinematic brilliance of Dolby Vision and the intricate detail of HDR10+, unlocks an expanded range of high brightness and contrast. Witness scenes with richer blacks, dazzling highlights, and an incredible level of detail that brings movies, shows, and games to life like never before. -Game at the Speed of Light with 144Hz Native Refresh Rate, 240Hz Gaming & ALLM: Level up your gaming prowess! Experience incredibly fluid and responsive gameplay with a 144Hz Native Refresh Rate, boosted to an ultra-smooth 240Hz for compatible gaming, coupled with ALLM (Auto Low Latency Mode). Immerse yourself in seamless virtual worlds with reduced lag and unparalleled clarity. -Experience Blockbuster Entertainment with IMAX Enhanced: Prepare for a truly cinematic experience in your own home! The TCL Q6C is IMAX Enhanced, meeting stringent performance standards for picture, sound, scale, and content, so you can enjoy movies as the filmmakers intended. -Immerse Yourself in a Symphony of Sound with ONKYO 2.1ch Speakers, Dolby Atmos & DTS Virtual:X: Prepare for audio that envelops you! Powerful ONKYO 2.1ch Speakers work in perfect harmony with Dolby Atmos and DTS Virtual:X to create a captivating surround-sound experience that fills your living room. From the subtle rustle of leaves to the thunderous roar of an explosion, every sound will place you right in the heart of the action. -AI-Powered Picture and Sound Perfection with AiPQ Pro Engine 3.0: Witness the future of intelligent entertainment! Our advanced AiPQ Pro Engine 3.0, driven by sophisticated AI algorithms, dynamically analyzes and optimizes both visuals and audio on a scene-by-scene basis. Experience picture clarity, vibrant colors, and immersive sound that are automatically fine-tuned for the ultimate viewing pleasure. -Effortless Control at Your Command with Hands-Free Voice Control: Embrace the convenience of a truly smart home! With built-in Google Assistant and seamless Alexa integration, controlling your TV and other smart devices is as simple as speaking. Change channels, adjust the volume, search for content, and manage your smart home - all with the power of your voice. A Masterpiece of Design: Where Elegance Meets Performance The TCL Q6C is not just a powerhouse of technology; it's a stunning addition to any modern living space. Its bezel-less ultra-slim metallic design exudes sophistication and seamlessly blends into your decor, while maximizing the screen real estate for an immersive viewing experience that captivates from every angle. Your Journey to Premium Entertainment Begins Now: The TCL Q6C will be available starting at an attractive price of Rs51,990 onwards, offered in a range of immersive screen sizes including 55-inch, 65-inch, and 75-inch to perfectly complement your individual entertainment needs and living space. Don't miss out! The TCL Q6C will be available exclusively on Amazon starting in May 2025. Prepare to redefine your home entertainment experience! About TCL Electronics: TCL Electronics is a globally recognized leader in consumer electronics, with a presence in over 160 countries. Specializing in the innovation and manufacturing of televisions, audio solutions, home appliances, smart devices, and displays, TCL has consistently pushed the boundaries of technology. Achieving the prestigious "Global Top 1" ranking in the Ultra-large screen TV Brand, "Global Top 1" ranking in Mini-LED TV Brand and being recognized as the "Global Top 1" in the Google TV Brand by OMDIA, TCL is dedicated to delivering future-ready, premium experiences worldwide. Visit TCL India at Stay Connected with TCL India:
